BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Policy

  Momenta Pharmaceuticals, Inc. Receives Regulatory Guidance On M-Enoxaparin ANDA

  April 30, 2008

   · 

  1 min read
• Business

  Hana Biosciences, Inc. Announces Conference Call On First Quarter Financial Results and Business Update

  April 30, 2008

   · 

  1 min read
• Business

  Barrier Therapeutics, Inc. Announces First Quarter 2008 Financial Results

  April 30, 2008

   · 

  1 min read
• Business

  Med BioGene Reports Financial Results for 2007

  April 30, 2008

   · 

  1 min read
• BioForest

  Wex Pharmaceuticals Inc. Announces Successful Reexamination of Key Patent Covering Uses of Tectin

  April 30, 2008

   · 

  1 min read
• Business

  Concert Pharmaceuticals, Inc. Raises $37 Million in Series C Financing

  April 30, 2008

   · 

  2 min read
• Eurand to Present At Upcoming Conferences

  April 30, 2008

   · 

  1 min read
• FDA

  FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals, Inc.'s TRELSTAR(R) DEPOT and TRELSTAR(R) LA

  April 30, 2008

   · 

  6 min read
• Genetown

  NUCRYST Pharmaceuticals Corp. Announces Management Realignment and R&D Portfolio Change; Discontinued Development of NPI 32101 for Inflammatory Bowel Disease (IBD)

  April 30, 2008

   · 

  1 min read
• Business

  Sanofi-Aventis (France) Encouraging First-Quarter 2008 Results

  April 30, 2008

   · 

  14 min read